Follow
Aditi Das, Ph.D.
Aditi Das, Ph.D.
Associate Professor, School of Chemistry and Biochemistry, Georgia Tech
Verified email at chemistry.gatech.edu - Homepage
Title
Cited by
Cited by
Year
De novo proteins from designed combinatorial libraries
MH Hecht, A Das, A Go, LH Bradley, Y Wei
Protein science 13 (7), 1711-1723, 2004
2652004
Anti-inflammatory ω-3 endocannabinoid epoxides
DR McDougle, JE Watson, AA Abdeen, R Adili, MP Caputo, JE Krapf, ...
Proceedings of the National Academy of Sciences 114 (30), E6034-E6043, 2017
1782017
Screening of type I and II drug binding to human cytochrome P450-3A4 in nanodiscs by localized surface plasmon resonance spectroscopy
A Das, J Zhao, GC Schatz, SG Sligar, RP Van Duyne
Analytical chemistry 81 (10), 3754-3759, 2009
1712009
Resonance surface plasmon spectroscopy: low molecular weight substrate binding to cytochrome P450
J Zhao, A Das, X Zhang, GC Schatz, SG Sligar, RP Van Duyne
Journal of the American Chemical Society 128 (34), 11004-11005, 2006
1452006
Redox potential control by drug binding to cytochrome P450 3A4
A Das, YV Grinkova, SG Sligar
Journal of the American Chemical Society 129 (45), 13778-13779, 2007
1342007
Integration of multi-omics data from mouse diversity panel highlights mitochondrial dysfunction in non-alcoholic fatty liver disease
KC Krishnan, Z Kurt, R Barrere-Cain, S Sabir, A Das, R Floyd, L Vergnes, ...
Cell systems 6 (1), 103-115. e7, 2018
1252018
Optimizations to achieve high-level expression of cytochrome P450 proteins using Escherichia coli expression systems
S Zelasko, A Palaria, A Das
Protein expression and purification 92 (1), 77-87, 2013
1232013
Modulation of the cytochrome P450 reductase redox potential by the phospholipid bilayer
A Das, SG Sligar
Biochemistry 48 (51), 12104-12112, 2009
1062009
Emerging class of omega-3 fatty acid endocannabinoids & their derivatives
JE Watson, JS Kim, A Das
Prostaglandins & other lipid mediators 143, 106337, 2019
1042019
Nanografting de novo proteins onto gold surfaces
Y Hu, A Das, MH Hecht, G Scoles
Langmuir 21 (20), 9103-9109, 2005
1002005
Recent advances in nanodisc technology for membrane protein studies (2012–2017)
JE Rouck, JE Krapf, J Roy, HC Huff, A Das
FEBS letters 591 (14), 2057-2088, 2017
952017
Endocannabinoid metabolism by cytochrome P450 monooxygenases
S Zelasko, WR Arnold, A Das
Prostaglandins & other lipid mediators 116, 112-123, 2015
752015
Resonance localized surface plasmon spectroscopy: Sensing substrate and inhibitor binding to cytochrome P450
J Zhao, A Das, GC Schatz, SG Sligar, RP Van Duyne
The Journal of Physical Chemistry C 112 (34), 13084-13088, 2008
672008
Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase
DR McDougle, A Kambalyal, DD Meling, A Das
Journal of Pharmacology and Experimental Therapeutics 351 (3), 616-627, 2014
642014
Comparative pharmacokinetics of Δ9-tetrahydrocannabinol in adolescent and adult male mice
A Torrens, V Vozella, H Huff, B McNeil, F Ahmed, A Ghidini, SV Mahler, ...
Journal of Pharmacology and Experimental Therapeutics 374 (1), 151-160, 2020
602020
Functional studies of N‐terminally modified CYP2J2 epoxygenase in model lipid bilayers
DR McDougle, A Palaria, E Magnetta, DD Meling, A Das
Protein Science 22 (7), 964-979, 2013
532013
Peroxidase activity of de novo heme proteins immobilized on electrodes
A Das, MH Hecht
Journal of inorganic biochemistry 101 (11-12), 1820-1826, 2007
522007
Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2
WR Arnold, AT Weigle, A Das
Journal of inorganic biochemistry 184, 88-99, 2018
482018
Ultra-thin layer MALDI mass spectrometry of membrane proteins in nanodiscs
MT Marty, A Das, SG Sligar
Analytical and bioanalytical chemistry 402, 721-729, 2012
432012
Incorporation of charged residues in the CYP2J2 FG loop disrupts CYP2J2–lipid bilayer interactions
DR McDougle, JL Baylon, DD Meling, A Kambalyal, YV Grinkova, ...
Biochimica et Biophysica Acta (BBA)-Biomembranes 1848 (10), 2460-2470, 2015
422015
The system can't perform the operation now. Try again later.
Articles 1–20